Skip to main content
Thomas Darling, MD, Dermatology, Bethesda, MD, National Institutes of Health Clinical Center

ThomasNDarlingMDPhD

Dermatology Bethesda, MD

Professor, Dermatology, Uniformed Services University

Dr. Darling is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Darling's full profile

Already have an account?

  • Office

    4301 Jones Bridge Rd
    Uniformed Services University
    Bethesda, MD 20814
    Phone(301) 295-3528
    Fax(301) 295-3150
  • Is this information wrong?

Education & Training

  • Clinical Center at the National Institutes of Health
    Clinical Center at the National Institutes of HealthResidency, Dermatology, 1994 - 1999
  • Duke University Hospital
    Duke University HospitalResidency, Dermatology, 1991 - 1994
  • University of North Carolina Hospitals
    University of North Carolina HospitalsInternship, Internal Medicine, 1990 - 1991
  • Duke University School of Medicine
    Duke University School of MedicineClass of 1990

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 1993 - 2022
  • American Board of Dermatology Dermatology

Awards, Honors, & Recognition

  • Fellow (FAAD) American Academy of Dermatology

Publications & Presentations

PubMed

Journal Articles

  • Safety and Efficacy of Low-Dose Sirolimus in the PIK3CA-Related Overgrowth Spectrum  
    Thomas N Darling, Brigitte C Widemann, Kristina I Rother, Nature

Lectures

  • Florida Society of Dermatology & Dermatologic Surgery (FSDDS) 2012 Annual Meeting 
    Florida Society of Dermatology & Dermatologic Surgery, Orlando, Florida - 5/25/2012

Press Mentions

  • Heart Failure Biomarker Linked to Rare Genetic Tumor-Causing Diseases
    Heart Failure Biomarker Linked to Rare Genetic Tumor-Causing DiseasesJuly 11th, 2017

Grant Support

  • Regulation of Dermal Fibroblasts in Skin Regeneration and HealingNATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES2012–Present
  • Novel In Vitro And Xenograft Models To Study Treatments For Tuberous SclerosisNational Cancer Institute2006–2007
  • Tumorigenesis In Tuberous SclerosisNational Cancer Institute2004–2007

Professional Memberships

Hospital Affiliations